Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Chubb Ltd (CB) vs Tilray Brands Inc (TLRY) Price & Performance

Chubb LtdTrade
Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

Chubb Ltd vs Tilray Brands Inc — how do they compare? Chubb Ltd trades at $340.75 (market cap $134.28B), while Tilray Brands Inc trades at $4.39 (market cap $540.74M). The key difference: Chubb Ltd is far larger — about 248.3× Tilray Brands Inc's market cap, and Chubb Ltd pays a 1.18% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.

CBTLRY
Market Cap
$134.28B$540.74M
Sector
FinancialsHealth
52-Week High
$361.17$21.00
52-Week Low
$265.99$4.31
Enterprise Value
$155.34B$637.89M
Dividend Yield
1.18%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Chubb Ltd

Chubb (CB) trades at $354.74, up 1.99% today, with a bullish technical outlook supported by moving averages and strong fundamental performance. Recent earnings beats, including Q1 2026 EPS of $6.82 versus $6.60 expected, highlight robust profitability with a net income margin of 18.46% and ROE of 16.2%. The company maintains disciplined capital deployment, with a recent $1.02 dividend declared for H1 2026.

The stock offers a compelling value with a P/E of 12.55 and consensus price target of $361.67, though near-term risks include catastrophe losses and softer commercial pricing. Long-term growth is supported by premium expansion and investment income, but investors should monitor underwriting margins and market volatility.

Tilray Brands Inc

TLRY trades at $4.46, up 0.9% on the day, amid a bearish technical signal and mixed earnings history. The company reported a net loss of $2.19 billion in 2025, with a negative net income margin of -156.67%, though revenue grew to $821.31 million. Analyst consensus is cautious with 65% hold ratings, and recent news highlights expansion in medical cannabis and new product launches.

The outlook remains challenged by persistent losses and high debt levels, but low valuation ratios like P/S of 0.54 and P/B of 0.35 may attract value investors. Key risks include profitability struggles and regulatory uncertainty, while potential catalysts include international expansion and upcoming earnings on July 28, 2026.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Chubb Ltd

ACE acquired Chubb in the first quarter of 2016 and assumed the Chubb name. The combination makes the new Chubb one of the largest domestic property and casualty insurers, with operations in 54 countries spanning commercial and personal P&C insurance, reinsurance, and life insurance.

Read more on CB

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY